ZADENVI 60 mg solution for injection in pre-filled syringe

  • DHPC
Active Ingredient
Strength
  • Denosumab: 60 mg
Dosage Form
Solution for injection in pre- filled syringe
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
Additional Communications section shown.

Direct Healthcare Professional Communications

  • Zadenvi HCP Letter

    Direct Healthcare Professional Communication (DHPC)

    PDF283.36 KB

Zentiva Pharma UK Limited

First Floor, Andrews House, College Road, Guildford, GU1 4QB UKMedInfo@zentiva.com

Telephone
+353818882243